GT Biopharma Announces Dr. Greg Berk, M.D. Joins Board of Directors

BEVERLY HILLS, CA / ACCESSWIRE / November 19, 2020 / GT Biopharma,…

Havn Life announces Voluntary Escrow of 6,300,000 Shares

The Voluntary Escrow serves further validates investors belief and support of Havn…

GT Biopharma Appoints Michael Handelman, CPA as Chief Financial Officer

BEVERLY HILLS, CA / ACCESSWIRE / November 18, 2020 / GT Biopharma,…

GT Biopharma Announces Former Abraxis CEO, Bruce J. Wendel as Vice Chairman of GTBP Board of Directors

BEVERLY HILLS, CA / ACCESSWIRE / November 17, 2020 / PGT Biopharma,…

GT Biopharma Announces Publication of GTB-3550 TriKE Interim Results at the Prestigious 62nd American Society of Hematology (ASH) Annual Meeting

TAMPA, FL / ACCESSWIRE / November 12, 2020 / GT Biopharma, Inc. (OTCQB:GTBP)…

Havn Life Announces Launch of a Range of Natural Health Products

The 7 initial formulations are designed to support and enhance memory and…

Havn Life Sciences to Support the First Modern Psilocybin Depression Study in Germany With MIND Foundation

The research will be led by Prof. Dr. Gerhard Gründer, the only…

GT Biopharma Announces Publication of Trike(TM) Results Targeting Multiple B7H3 Positive Cancers

BEVERLY HILLS, CA / ACCESSWIRE / October 21, 2020 / GT Biopharma, Inc.…

GT Biopharma Announces Selection of GTB-3550 Interim Results for Presentation at 62nd (ASH) American Society of Hematology Annual Meeting

BEVERLY HILLS, CA / ACCESSWIRE / October 15, 2020 / GT Biopharma,…

Micron Waste’s Subsidiary Ships Medical Grade Face Masks to a British Columbia Municipality and Submits Bids to Provincial Government Tenders

VANCOUVER, BC, Oct. 14, 2020 /CNW/ – Micron Waste Technologies Inc. (“Micron”…